Literature DB >> 20113296

Identification of three novel mutations [-41 (A>C), codon 24 (-G), and IVS-I-109 (-T)], in a study of beta-thalassemia alleles in the Isfahan region of Iran.

Rasoul Salehi1, Christopher A Fisher, Patricia A Bignell, Gilda Eslami, John M Old.   

Abstract

Beta-thalassemia (beta-thal) is one of the most common autosomal recessive disorders in Iran, with more than 15,000 registered cases of thalassemia major in the country. Iran has a multiethnic society and knowledge of the mutation spectrum and regional distribution is an essential requirement for health planning and a prenatal diagnosis program. We have determined the spectrum of mutations in patients from the Isfahan region of Iran. A study of 190 chromosomes revealed 24 different mutations, including three novel ones: -41 (A>C), IVS-I-109 (-T) and codon 24 (-G). The most common mutation was IVS-II-1 (G>A) (20.5%), followed by IVS-I-5 (G>C) (11%). The findings for the Isfahan region confirm the extremely heterogeneous nature of the molecular basis of beta-thal in Iran. The results show that a strategy of using the amplification refractory mutation system-polymerase chain reaction (ARMS-PCR) for 14 of the most common mutations and DNA sequencing for the rare mutations can be used for prenatal diagnosis of beta-thal in this region.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20113296     DOI: 10.3109/03630260903554894

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  3 in total

1.  Effect of hepatic iron concentration and viral factors in chronic hepatitis C-infected patients with thalassemia major, treated with interferon and ribavirin.

Authors:  Maryam Jafroodi; Ramin Asadi; Abtin Heydarzadeh; Sepiedeh Besharati
Journal:  Int J Gen Med       Date:  2011-07-13

2.  Hemoglobin Q-Iran detected in family members from Northern Iran: a case report.

Authors:  Mohammad Khorshidi; Payam Roshan; Nooshin Bayat; Mohammad Reza Mahdavi; Hossein Najmabadi
Journal:  J Med Case Rep       Date:  2012-02-06

Review 3.  Genetic epidemiology, hematological and clinical features of hemoglobinopathies in Iran.

Authors:  Zohreh Rahimi
Journal:  Biomed Res Int       Date:  2013-06-18       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.